Trial
NCT03113994
Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dr. B. Catharine. Craven
Collaborators
The Craig H. Neilsen Foundation; Toronto Rehabilitation Institute; University Health Network, Toronto; University of Miami; Rick Hansen Institute
Condition
Spinal Cord Injuries
Intervention
Rosuvastatin Calcium
Why stopped
COVID-19 Pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13